GLPBio

Gingerenone A

Catalog No.: GB10587Purity:>98.00%
Gingerenone A is an orally active Nrf2-Gpx4 activator with an EC50 value of 24μM.

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


Gingerenone A
Cas No.: 128700-97-0
5mgIn Stock
$56.00
1
10mgIn Stock
$97.00
1
25mgIn Stock
$212.00
1
50mgIn Stock
$351.00
1
100mgIn Stock
$585.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

Gingerenone A is an orally active Nrf2-Gpx4 activator with an EC50 value of 24μM[1]. Nrf2-Gpx4 pathway is a key signaling pathway in cellular antioxidant defense[2]. Gingerenone A is commonly used for research on anti-inflammation, anti-diabetes, anti-tumor, and aging-related mechanisms[3].

In vitro, treatment of 3T3-L1 cells or L6 myotubes with Gingerenone A(2.5–40μM) for 5h induced phosphatidylinositide-3 kinase (PI3K) feedback activation and increased insulin receptor tyrosine phosphorylation in L6 myotubes and IRS-1 binding to the PI3K[4]. Treatmen of MCF7 and MDA-MB-231 cells with 80µM Gingerenone A increased ROS levels and induced G2/M phase delay and senescence[5].

In vivo, oral administration of high-fat diet (HFD)-induced obese mice with Gingerenone A (50mg/kg/day) for 15weeks significantly reduced fat mass increase and inhibited obesity and adipose tissue inflammation in mice by decreasing adipocyte size[6]. Oral treatment of dextran sodium sulfate (DSS)-induced secondary liver injury (SLI) mice with Gingerenone A(5, 20mg/kg, p.o., once a day for 7days) alleviated DSS-induced hepatic pathological damage, liver parameters, and cytokine levels, increased the antioxidant enzyme activities, attenuated ferroptosis in DSS-induced liver injury and upregulated Gpx4 expression[7].

References:
[1] Changtam, C., de Koning, H. P., Ibrahim, H., Sajid, M. S., Gould, M. K., & Suksamrarn, A. (2010). Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. European journal of medicinal chemistry, 45(3), 941–956.
[2] Zhang, S., Sun, Z., Jiang, X., Lu, Z., Ding, L., Li, C., Tian, X., & Wang, Q. (2022). Ferroptosis increases obesity: Crosstalk between adipocytes and the neuroimmune system. Frontiers in immunology, 13, 1049936.
[3] Moaddel, R., Rossi, M., Rodriguez, S., Munk, R., Khadeer, M., Abdelmohsen, K., Gorospe, M., & Ferrucci, L. (2022). Identification of gingerenone A as a novel senolytic compound. PloS one, 17(3), e0266135.
[4] Chen, J., Sun, J., Prinz, R. A., Li, Y., & Xu, X. (2018). Gingerenone A Sensitizes the Insulin Receptor and Increases Glucose Uptake by Inhibiting the Activity of p70 S6 Kinase. Molecular nutrition & food research, 62(23), e1800709.
[5] Yu, T. J., Tang, J. Y., Shiau, J. P., Hou, M. F., Yen, C. H., Ou-Yang, F., Chen, C. Y., & Chang, H. W. (2022). Gingerenone A Induces Antiproliferation and Senescence of Breast Cancer Cells. Antioxidants (Basel, Switzerland), 11(3), 587.
[6] Suk, S., Kwon, G. T., Lee, E., Jang, W. J., Yang, H., Kim, J. H., Thimmegowda, N. R., Chung, M. Y., Kwon, J. Y., Yang, S., Kim, J. K., Park, J. H. Y., & Lee, K. W. (2017). Gingerenone A, a polyphenol present in ginger, suppresses obesity and adipose tissue inflammation in high-fat diet-fed mice. Molecular nutrition & food research, 61(10), 10.1002/mnfr.201700139.
[7] Chen, Y., Zhu, S., Chen, Z., Liu, Y., Pei, C., Huang, H., Hou, S., Ning, W., & Liang, J. (2022). Gingerenone A Alleviates Ferroptosis in Secondary Liver Injury in Colitis Mice via Activating Nrf2-Gpx4 Signaling Pathway. Journal of agricultural and food chemistry, 70(39), 12525–12534.

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

3T3-L1 adipocytes

Preparation Method

3T3-L1 adipocytes were cultured in serum-free medium overnight. Gingerenone A at indicated concentrations (2.5–40μM) or PF-4708671 (10μM) was added and incubated for 5h, followed by stimulation with 100nM insulin for 20minutes. Unstimulated cells were included as a negative control. Cells were harvested and lysed in NP-40 lysis buffer containing 1% NP-40; 50mM Tris-HCl, pH 8.0; 150mM NaCl; 5mM EDTA; 10μg/ml aprotinin; 10μg/ml leupeptin; 1mM phenylmethylsulfonyl fluoride; 2mM sodium pervanadate. Protein phosphorylation and total amounts of proteins were analyzed by Western blot with the indicated antibodies.

Reaction Conditions

2.5, 5, 10, 20 and 40μM; 5h

Applications

Gingerenone A induced phosphatidylinositide-3 kinase (PI3K) feedback activation and increased insulin receptor tyrosine phosphorylation in L6 myotubes and IRS-1 binding to the PI3K.

Animal experiment [2]:

Animal models

SPF Male C57 mice

Preparation Method

The mice were housed at a temperature of 20−24 °C, relative humidity of 55 ± 10%, and a light/dark cycle of 12−12h. the SLI mouse model was treated by 7days of dextran sodium sulfate (DSS) free drinking. mice were randomly grouped into an average of 10 mice per group. The groups were set as the control group (Ctrl), 4% DSS group, 4% DSS+5-ASA (50mg/kg) group, 4% DSS+Gingerenone A (5mg/kg) group (GAL), and 4% DSS+Gingerenone A (20mg/kg) group (GAH). During DSS treatment, mice in the control were given distilled water, and the rest of the groups were given the corresponding drugs; body weights were assessed daily. The livers were removed, and a portion was cut and soaked in 4% paraformaldehyde for pathology.

Dosage form

5,20mg/kg/day for 7days; p.o.

Applications

Gingerenone A alleviated DSS-induced hepatic pathological damage, liver parameters, and cytokine levels, increased the antioxidant enzyme activities, attenuated ferroptosis in DSS-induced liver injury and upregulated Gpx4 expression.

References:
[1]Chen, J., Sun, J., Prinz, R. A., Li, Y., & Xu, X. (2018). Gingerenone A Sensitizes the Insulin Receptor and Increases Glucose Uptake by Inhibiting the Activity of p70 S6 Kinase. Molecular nutrition & food research, 62(23), e1800709.
[2]Chen, Y., Zhu, S., Chen, Z., Liu, Y., Pei, C., Huang, H., Hou, S., Ning, W., & Liang, J. (2022). Gingerenone A Alleviates Ferroptosis in Secondary Liver Injury in Colitis Mice via Activating Nrf2-Gpx4 Signaling Pathway. Journal of agricultural and food chemistry, 70(39), 12525–12534.

وثائق المنتج (Product Documents)

Purity:>98.00%Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
128700-97-0
الصيغة الجزيئية
C21H24O5
الوزن الجزيئي
356.41
الذوبانية
DMSO : 100 mg/mL (280.58 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
التخزين
2-8℃
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for Gingerenone A

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%